Partners
|
RxEDO has partnered with Argus Health Systems, Inc. for claims processing. Argus is a leading provider of information services and administrative support for pharmacy program management. Argus was established in 1983, and by 1986 had become a pioneer in electronic claims processing. The company quickly grew to become one of the largest pharmacy claims processors in the industry-with more than 256 million claims processed in 2006. Headquartered in Kansas City, MO, Argus employs approximately 320 associates. Argus is privately held and free from conflicts of interest resulting from industry ownership. The company is a joint venture of DST Systems, Inc., the nation's largest mutual fund transfer agent, and Financial Holding Corporation, the holding company for the Americo Life companies. DST operates the Winchester Data Center, one of the largest and most sophisticated computer facilities dedicated to commercial data processing in the United States. Companies in several industries rely on DST's data center to provide continuous and instantaneous access to data. Argus maintains connections with this state-of-the-art center. |
|
United Resource Group specializes in helping to identify the needs of the national workforce and applying proven technology solutions. Our experience encompasses a broad history with insurance companies, health maintenance organizations, preferred provider organizations, business process outsourcing firms, employers and employer coalitions, pharmacy benefit organizations, and the extensive community serving the needs of each. We add forward-looking innovation to this equation and couple that with solid investment returns.
|
The
Jāsos®
Group
provides a proprietary method to manage pharmacy utilization and help
prescribers make medically sound, cost-effective drug choices through our
RxSpiraLimit™ Program.
Our clinicians target pharmacy costs in five key areas: Data Analysis,
Physician Support, Physician Intervention, Patient Support, and Drug
Education.
We work with physicians to reduce the daily obstacles they encounter
when prescribing, such as managing multiple formularies, combating direct to
consumer advertising, and incorporating the latest, unbiased information.
As a result, our
RxSpiraLimit™ Program
typically reduces pharmacy utilization costs 10% - 20% or more and usually
shows bottom line results within 90 days for our clients.
Most importantly, so there is never a financial risk for our
RxSpiraLimit™ program, we
guarantee a 50% return on program retainer fees – or we pay the
difference. For more
information, please contact the Jāsos Group at results@jasos.com. |